# LIVDELZI — FDA application NDA217899

Informational only - not investment advice.

Application NDA217899 · type NDA · FDA status: approved · original approval 2024-08-14

Listed sponsor: GILEAD SCIENCES INC · [GILD company profile](/company/GILD/) · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

## FDA application facts

| Product | FDA-listed trade name | Active ingredient | Dosage form | Route | Strength | Marketing status | TE code | RLD |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001 | LIVDELZI | SELADELPAR LYSINE | CAPSULE | ORAL | EQ 10MG BASE | Prescription | not listed | Yes |

## Orange Book patent and exclusivity listings

- Patent 7301050, product 001; listed patent expiry date: 2026-08-02.
- Patent 7709682, product 001; listed patent expiry date: 2026-09-13.
- Patent 10272058, product 001; listed patent expiry date: 2035-03-19.
- Patent 11406611, product 001; listed patent expiry date: 2035-03-19.
- Patent 11596614, product 001; listed patent expiry date: 2035-03-19.
- Patent 9486428, product 001; listed patent expiry date: 2035-03-19.
- Exclusivity NCE, product 001; listed exclusivity date: 2029-08-14.
- Exclusivity ODE-486, product 001; listed exclusivity date: 2031-08-14.

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

## Compound cross-links

- SELADELPAR LYSINE · UNII N1429130KR · [lmmol compound WTKSWPYGZDCUNQ-JZXFCXSPSA-N](https://lmmol.com/compound/WTKSWPYGZDCUNQ-JZXFCXSPSA-N)

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

## Related pages

- [Sponsor company](/company/GILD/)
- [FDA-approved application index](/drug/)
- [Large-cap biopharma](/compare/pharma/)

Sources: https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files · https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files · https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA217899. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.